von Stefanie Simons | Jun 3, 2019
Keystone Symposium June 18th, 2019 – Keystone, CO, USA Learn more Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA. News & Events: Keystone...
von Dagmar jürgens | Mai 6, 2019
Neuro4D Conference 2019 May 14th – 15th, 2019 – Mainz, Germany Learn more May 13th, 2019: Dieter Willbold will present PRI-002 at the Neuro4D Confernce in Mainz, Germany. May 14th, 2019: Antje Willuweit will present PRI-003 at the Neuro4D Conference in...
von Dagmar jürgens | Mai 6, 2019
Seed Investment March 28th, 2019 Priavoid obtained seed investment. News & Events: Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize Prof. Willbold´s interview with PharmaVentures...
von Dagmar jürgens | Mai 3, 2019
CEOs of Priavoid 21st February 2019: Dr. Antje Willuweit and Dr. Sabine Willbold became CEOs of Priavoid. News & Events: Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize Prof....
von Dagmar jürgens | Mrz 26, 2019
AD/PD 2019 March 26th – 31st, 2019 – Lisbon Learn more 29th March 2019: Dieter Willbold presented PRI-002 on the AD/PD 2019 in Lisbon.For further information please click the learn more button above. News & Events: Keystone Symposium Neuro4D Conference...
Neue Kommentare